• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Musculoskeletal System Disorders Market

    ID: MRFR/HC/17908-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Musculoskeletal System Disorders Market Research Report By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis), By Treatment (Biologics, Corticosteroids, Physical Therapy, Protein Therapy, Composite Grafts) and By End User (Hospitals and Clinics, Ambulatory Surgical Centers) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Musculoskeletal System Disorders Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    US Musculoskeletal System Disorders Market Summary

    The US Musculoskeletal System Disorders market is poised for substantial growth, with a projected valuation increase from 628.2 USD Million in 2024 to 1294.0 USD Million by 2035.

    Key Market Trends & Highlights

    US Musculoskeletal System Disorders Key Trends and Highlights

    • The market is expected to grow from 628.2 USD Million in 2024 to 1294.0 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 6.79% is anticipated from 2025 to 2035.
    • The increasing prevalence of musculoskeletal disorders is likely to drive market expansion.
    • Growing adoption of advanced treatment technologies due to rising patient demand is a major market driver.

    Market Size & Forecast

    2024 Market Size 628.2 (USD Million)
    2035 Market Size 1294.0 (USD Million)
    CAGR (2025-2035) 6.79%

    Major Players

    Smith and Nephew, Hologic, Medtronic, Abbott Laboratories, Boston Scientific, Baxter International, Thermo Fisher Scientific, DePuy Synthes, Stryker, B. Braun Melsungen, NuVasive, Orthofix Medical, MediNatura, Johnson and Johnson, Zimmer Biomet

    US Musculoskeletal System Disorders Market Trends

    The US Musculoskeletal System Disorders Market is experiencing notable trends driven by an aging population, rising obesity rates, and increased physical activity among younger adults. As the baby boomer generation continues to age, there is a higher prevalence of musculoskeletal disorders such as osteoarthritis and osteoporosis.

    Additionally, the growing rates of obesity in the US contribute to increased wear and tear on joints, leading to a surge in the demand for treatments and therapies for various musculoskeletal conditions. The market is also seeing a shift towards minimally invasive procedures and non-invasive treatment options, as patients are becoming more interested in these alternatives due to shorter recovery times and reduced risks.

    Opportunities in the US market include advancements in biotechnology and the development of personalized medicine tailored to individual patient needs. Research into new therapies and regenerative medicine holds promise for improved outcomes in treating musculoskeletal disorders. The integration of telemedicine is also creating opportunities, enabling patients to access care and rehabilitation services remotely, which can increase patient engagement and adherence to treatment plans.

    In recent times, there has been a surge in the popularity of wellness and fitness products aimed at injury prevention and rehabilitation. The focus on preventative measures demonstrates a shift in perspective, with more emphasis on maintaining musculoskeletal health rather than solely treating disorders once they occur. The growing utilization of wearable technology and mobile health applications is also impacting patient management, allowing for better monitoring and early intervention. Overall, these trends reflect an evolving market landscape in the US, driven by technological advancements and changing patient preferences focused on proactive approaches to musculoskeletal health.

    Market Segment Insights

    Musculoskeletal System Disorders Market Type Insights

    The US Musculoskeletal System Disorders Market is primarily categorized by Type, providing a comprehensive overview of prevalent conditions affecting millions of Americans. Of these, Osteoarthritis stands out as the most common joint disorder, affecting the older population significantly. This degenerative condition not only impacts physical mobility but also contributes extensively to healthcare costs, influencing research and treatment paradigms.

    Similarly, Rheumatoid Arthritis, an autoimmune disorder, is known for its aggressive nature that affects multiple joints, leading to chronic pain and disability. The increasing prevalence of this condition in the US population, particularly among women, underscores the necessity for innovative therapies and management strategies.

    Osteoporosis also plays a vital role in this market, being a leading cause of fractures among older individuals, particularly postmenopausal women. The demographic changes in the US, such as an aging population, are expected to drive the demand for treatments and preventative measures against this silent disease.

    Psoriatic Arthritis, which is both a skin and joint condition, has received growing attention due to its complexity and the challenges it presents in treatment. It affects a significant segment of the population who suffer from psoriasis, leading to a specialized approach in therapy and management.

    Furthermore, Ankylosing Spondylitis, a type of inflammatory arthritis that primarily affects the spine, represents another crucial area within this market. Its association with chronic pain and fatigue has led to increased demand for targeted therapies and improved patient care options.

    The overall insights reveal that the US Musculoskeletal System Disorders Market is experiencing significant growth due to the rising prevalence of these conditions, along with the continuous advancements in treatments and methodologies. The challenges in managing these disorders are complemented by growing opportunities in medical technology and research, aiming to enhance the quality of life for affected individuals. With ongoing innovation and a focus on patient-centered care, each type within the market represents a strategic area for stakeholders, paving the way for improved healthcare outcomes across the United States.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Musculoskeletal System Disorders Market Treatment Insights

    The Treatment segment of the US Musculoskeletal System Disorders Market is characterized by a diverse array of approaches aimed at alleviating pain and enhancing functionality for patients suffering from various disorders. Biologics have gained popularity due to their ability to promote healing, with a focus on utilizing the body’s own biological processes.

    Corticosteroids remain widely used in treating inflammation and pain, providing rapid relief, which makes them significant in clinical settings. Physical Therapy plays a crucial role in rehabilitation, focusing on improving mobility and strength, thus highlighting its significance in conservative treatment plans.

    Protein Therapy stands at the forefront of innovative treatments, utilizing specific proteins to facilitate recovery and enhance healing. Composite Grafts represent an evolving area in tissue repair, as they often combine different materials to leverage various biological responses, making them a preferred choice for complex musculoskeletal injuries.

    The growing prevalence of musculoskeletal disorders in the US necessitates an exploration of these treatment methods, driven by advancements in technology and an increasing understanding of patient-centered care. As the market evolves, these treatment modalities are expected to play a pivotal role in addressing the changing needs of patients with musculoskeletal conditions.

    Musculoskeletal System Disorders Market End User Insights

    The End User segment of the US Musculoskeletal System Disorders Market plays a vital role in addressing the growing incidence of musculoskeletal conditions, which significantly impact the quality of life of many individuals across the country. Hospitals and Clinics constitute a major portion of this segment, providing a comprehensive range of services from diagnosis to surgical interventions.

    The importance of these facilities stems from their ability to offer specialized care, advanced imaging technologies, and postoperative rehabilitation, crucial for effective recovery. On the other hand, Ambulatory Surgical Centers have emerged as an increasingly significant part of the market, owing to their efficiency in performing outpatient procedures, thereby reducing costs and wait times for patients.

    Their role is particularly prominent in minimally invasive surgeries, which have been gaining traction due to shorter recovery times and lower rates of complications. Factors driving growth in this segment include an aging population and increased awareness of musculoskeletal disorders. However, challenges such as rising healthcare costs and stringent regulations may hinder market expansion. Nevertheless, the ongoing advancements in medical technology and improvement in healthcare infrastructure continue to present numerous opportunities for growth within the US Musculoskeletal System Disorders Market.

    Get more detailed insights about US Musculoskeletal System Disorders Market

    Key Players and Competitive Insights

    The US Musculoskeletal System Disorders Market is a dynamic and rapidly evolving landscape characterized by a growing demand for innovative treatment options and advanced technologies. This segment, which encompasses a variety of conditions such as arthritis, osteoporosis, and injuries related to bones and joints, is influenced by the aging population, increased awareness of musculoskeletal health, and advancements in medical devices and therapeutics.

    Competitive insights within this market reveal a diverse array of players, each vying to establish their presence through strategic initiatives such as research and development investments, product launches, and partnerships. Companies are not only focusing on improving existing therapies but are also exploring regenerative medicine and minimally invasive alternatives to enhance patient outcomes and optimize recovery times.

    Smith and Nephew is recognized as a strong competitor in the US Musculoskeletal System Disorders Market, contributing significantly through its innovative product offerings and strong market presence. The company has established itself with a reputation for high-quality orthopedic devices, particularly in the areas of joint repair and reconstruction.

    Smith and Nephew's strengths lie in its commitment to research and development, leading to the creation of advanced solutions that cater to various musculoskeletal conditions. The company's strategic collaborations and focus on enhancing its product lines bolster its competitive standing in the marketplace, allowing it to consistently address the evolving needs of healthcare professionals and patients alike within the United States.

    Hologic is another key player in the US Musculoskeletal System Disorders Market, emphasizing women's health as part of its broader portfolio. The company offers a range of diagnostic and therapeutic solutions specifically designed to monitor and manage musculoskeletal disorders.

    Hologic's strengths include its innovative technology and a strong emphasis on research that aligns with emerging trends in women’s health and bone health management. The company has solidified its presence through strategic mergers and acquisitions that enhance its product offerings, allowing it to remain competitive and responsive to the changing needs of the market. Hologic’s focus on advanced imaging and diagnostic capabilities strengthens its position, making it a formidable contender in providing comprehensive solutions tailored to musculoskeletal disorders in the US.

    Key Companies in the US Musculoskeletal System Disorders Market market include

    Industry Developments

    The US Musculoskeletal System Disorders Market has seen significant developments recently, driven by advancements in technology and an increasing demand for innovative treatments. Smith and Nephew announced the launch of a new orthopedic surgical product aimed at enhancing recovery outcomes in October 2023.

    Hologic has focused on expanding its product line to include advanced imaging solutions tailored for musculoskeletal health, reinforcing its commitment to this sector. Medtronic is actively working on expanding its minimally invasive surgical solutions, addressing patient needs more effectively as of September 2023.

    In terms of mergers and acquisitions, DePuy Synthes finalized a strategic partnership with a small medical device company in August 2023, aimed at enhancing its product offerings in bone repair solutions. Other noteworthy happenings include Zimmer Biomet receiving FDA approval for its new orthopedic device designed to improve surgical accuracy in knee replacements in July 2023.

    The growth in market valuation, supported by continuous Research and Development initiatives from companies like Abbott Laboratories and Stryker, has led to increased competition and innovation in the US market focused on musculoskeletal disorders, positively impacting patient care and treatment outcomes.

    Market Segmentation

    Musculoskeletal System Disorders Market Type Outlook

    • Rheumatoid Arthritis
    • Osteoarthritis
    • Osteoporosis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis

    Musculoskeletal System Disorders Market End User Outlook

    • Hospitals and Clinics
    • Ambulatory Surgical Centers

    Musculoskeletal System Disorders Market Treatment Outlook

    • Biologics
    • Corticosteroids
    • Physical Therapy
    • Protein Therapy
    • Composite Grafts

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 588.25(USD Million)
    MARKET SIZE 2024 628.25(USD Million)
    MARKET SIZE 2035 1294.02(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.789% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Smith and Nephew, Hologic, Medtronic, Abbott Laboratories, Boston Scientific, Baxter International, Thermo Fisher Scientific, DePuy Synthes, Stryker, B. Braun Melsungen, NuVasive, Orthofix Medical, MediNatura, Johnson and Johnson, Zimmer Biomet
    SEGMENTS COVERED Type, Treatment, End User
    KEY MARKET OPPORTUNITIES Increased aging population demand, Innovative therapeutic developments, Telehealth for remote treatment, Rising prevalence of obesity, Enhanced diagnostics and imaging technologies
    KEY MARKET DYNAMICS increasing aging population, rising prevalence of disorders, advancements in treatment options, growing healthcare expenditure, increased awareness and education
    COUNTRIES COVERED US

    FAQs

    What is the projected market size of the US Musculoskeletal System Disorders Market in 2024?

    The US Musculoskeletal System Disorders Market is expected to be valued at 628.25 million USD in 2024.

    What will be the market size of the US Musculoskeletal System Disorders Market by 2035?

    By 2035, the market is expected to reach a valuation of 1294.02 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Musculoskeletal System Disorders Market from 2025 to 2035?

    The market is projected to grow at a CAGR of 6.789% during the forecast period from 2025 to 2035.

    Which sub-segment of the US Musculoskeletal System Disorders Market has the largest share in 2024?

    Osteoarthritis is expected to hold the largest share, valued at 200.0 million USD in 2024.

    What will be the market value of Rheumatoid Arthritis by 2035?

    The market value for Rheumatoid Arthritis is anticipated to reach 300.0 million USD by 2035.

    Who are the key players in the US Musculoskeletal System Disorders Market?

    Major players include Smith and Nephew, Hologic, Medtronic, Abbott Laboratories, and Boston Scientific among others.

    What is the expected market size for Osteoporosis in 2024?

    The market size for Osteoporosis is valued at 120.0 million USD in 2024.

    What opportunities and challenges are present in the US Musculoskeletal System Disorders Market?

    Opportunities include technological advancement in treatment options while challenges relate to the increasing prevalence of musculoskeletal disorders.

    What will be the value of Psoriatic Arthritis in 2035?

    The market for Psoriatic Arthritis is expected to be valued at 180.0 million USD by 2035.

    How is the Ankylosing Spondylitis market expected to grow from 2024 to 2035?

    Ankylosing Spondylitis is expected to grow from 68.25 million USD in 2024 to 174.02 million USD by 2035.

    US Musculoskeletal System Disorders Market Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials